EMEA-002016-PIP04-20
Key facts
Invented name |
Piqray
|
Active substance |
Alpelisib
|
Therapeutic area |
Oncology
|
Decision number |
P/0122/2021
|
PIP number |
EMEA-002016-PIP04-20
|
Pharmaceutical form(s) |
All pharmaceutical forms
|
Condition(s) / indication(s) |
|
Route(s) of administration |
All routes of administration
|
Contact for public enquiries |
Novartis Europharm Limited
E-mail: paediatric.enquiries@novartis.com |
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|